Product Code: ETC4642247 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Infectious Disease Biomarker Testing Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Canada Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Canada Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Canada Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Canada Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Canada Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Canada |
4.2.2 Growing awareness about the importance of early disease detection |
4.2.3 Technological advancements in biomarker testing methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biomarker testing |
4.3.2 High costs associated with biomarker testing procedures |
4.3.3 Limited accessibility to biomarker testing facilities in remote areas |
5 Canada Infectious Disease Biomarker Testing Market Trends |
6 Canada Infectious Disease Biomarker Testing Market Segmentations |
6.1 Canada Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2021-2031F |
6.1.3 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.1.4 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2021-2031F |
6.2 Canada Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2021-2031F |
6.2.3 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2021-2031F |
6.2.4 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2021-2031F |
6.2.5 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2021-2031F |
6.2.6 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2021-2031F |
6.2.7 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2021-2031F |
6.3 Canada Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2021-2031F |
6.3.3 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2021-2031F |
6.3.4 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.5 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2021-2031F |
6.3.6 Canada Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2021-2031F |
7 Canada Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Canada Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Canada Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Canada Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Average turnaround time for biomarker testing results |
8.2 Number of research and development initiatives in the field of infectious disease biomarker testing |
8.3 Adoption rate of biomarker testing technologies in healthcare facilities |
9 Canada Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Canada Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Canada Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Canada Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Canada Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Canada Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2024 |
10.2 Canada Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |